STILNasdaq StockholmMedical Instruments & SuppliesIFRS · SEK

Stille

Stille is a Swedish medical technology company that designs, manufactures, and sells premium surgical instruments and surgical tables. Its business is organized around specialized products for operating rooms, with production and commercial presence in Sweden and several international markets.

Revenue175m SEK
−69.3 %y/y
Operating profit (EBIT)73.2m SEK
+4.0 %y/y
EBIT margin41.9%
+29.5 ppy/y
Net income15.0m SEK
−73.2 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

0200400600m SEK2020: 143 m SEK2020: EBIT 15 m SEK20202021: 187 m SEK2021: EBIT 20 m SEK20212022: 246 m SEK2022: EBIT 32 m SEK20222023: 295 m SEK2023: EBIT 45 m SEK20232024: 570 m SEK2024: EBIT 70 m SEK20242025: 175 m SEK2025: EBIT 73 m SEK202517573
RevenueOperating profit (EBIT)

Business

Share of revenue
Surgical Instruments72 %

Premium hand-held and specialty instruments used in operating rooms.

Surgical Tables28 %

Operating tables and table systems for image-guided and general surgery.

Customers

Stille sells primarily to hospitals, surgical centers, and healthcare providers that need specialized operating-room equipment. Its products are also purchased through distributors and strategic partners that serve surgeons and medical institutions in multiple countries. Demand is tied to procedure volumes, replacement cycles, and the need for high-quality instruments and tables in niche surgical specialties.

Hospitals and surgical departments

Buy surgical instruments and tables for operating rooms and specialty procedures.

Distributors and strategic partners

Purchase and resell Stille products to extend geographic reach and market access.

Surgeons and clinical specialists

Influence product selection based on precision, quality, and workflow fit.

Healthcare systems and clinics

Buy replacement and upgrade equipment for specialized surgical use.

Strategy

Stille’s strategy centers on premium product leadership, sales expansion through strategic partners, operational excellence, and acquisitions. The company aims to deepen its position in niche clinical segments where product quality, brand reputation, and distribution reach are important competitive advantages.

Premium product leadershipMedium term

Supports pricing power and differentiation in specialized surgical niches.

Sales expansion through partnersShort term

Extends market reach without relying only on direct sales.

Operational excellenceShort term

Improves delivery reliability, lead times, and manufacturing scalability.

AcquisitionsMedium term

Adds products, brands, and channels that broaden the portfolio.

Geography

Stille is headquartered in Torshälla, Sweden, where it also has sales, R&D, and production. The company also operates from Germany, Switzerland, the UK, the US, and the UAE, with sales, service, assembly, and production activities supporting international distribution.

Risks

Stille is exposed to supply-chain disruption, currency movements, and demand variability in hospital purchasing cycles. As a medical device company, it also faces product quality, regulatory, and competitive risks, while acquisitions add integration and valuation uncertainty.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Foreign exchange exposure3Customer investment cycle volatility4Acquisition integration and earnout risk5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Supply-chain and component shortagesImpact: High

    Specialty instruments and tables depend on timely supplier deliveries and critical parts.

    Exposure: Surgical Instruments and Surgical Tables

  2. Product safety and field corrective actionsImpact: High

    Medical devices can require remediation if performance or safety issues arise.

    Exposure: Imaging-compatible table systems

  3. Foreign exchange exposureImpact: MediumLikelihood: Low

    International sales and sourcing create USD and EUR translation and transaction effects.

    Exposure: USD and EUR flows

  4. Customer investment cycle volatilityImpact: MediumLikelihood: Low

    Hospitals may delay capital purchases and replacement orders.

    Exposure: Surgical Tables and higher-value instruments

  5. Acquisition integration and earnout riskImpact: MediumLikelihood: Low

    Purchased businesses can create integration complexity and contingent liabilities.

    Exposure: S&T and Surgical Holdings acquisitions

Accounting

Judgemental items
Business combination accounting

Acquisitions add goodwill, brands, customer relationships, and contingent consideration.

Impact: Affects balance sheet, amortization, and future impairment risk

Intangible asset useful lives

Customer relationships and software are amortized over estimated lives.

Impact: Impacts operating profit and comparability over time

Goodwill and brand impairment

Acquired assets must be tested if market or performance assumptions weaken.

Impact: Could create non-cash charges

Hedge accounting for USD and EUR flows

The company hedges internal and net currency flows to reduce volatility.

Impact: Affects reported financial items and equity reserves

Contingent consideration / earnouts

Acquisition-related earnouts are discounted and remeasured.

Impact: Can change liabilities and profit or loss

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Stille (STIL) Revenue, Earnings & Financials 2025 – Clarifo